The M variant of encephalomyocarditis (EMC) 1 virus produces a diabetes-like syndrome in mice by infecting and destroying pancreatic beta cells (1-3). The severity of the diabetes correlates with the degree of virus-induced beta cell damage (4, 5). Only certain inbred strains of mice develop diabetes, and susceptibility to EMC virusinduced diabetes is inherited as an autosomal recessive trait (2, 6-8). The genetic factors controlling susceptibility operate at the level of the beta cell, and whether a particular strain of mouse develops diabetes appears to be related to differences in the permissiveness of beta cells to infection with EMC virus (9, 10).
times in beta cell cultures (9) . The virus then was passaged five additional times in SJL/J male mice and harvested from hearts. Virus titer was determined by plaque assay on secondary mouse embryo (SME) cells (9) .
Plaque Purification. The M variant of EMC virus, prepared as described above, was diluted to a concentration of 1 PFU/ml, and 0.1-ml aliquots were allowed to adsorb to monolayers of SME cells grown in 16-well cluster dishers (9-mm-diameter wells). After adsorption for 1 h at 37°C, cultures were overlaid with 1.5% (wt/vol) methylcellulose in Eagle's minimal essential medium that contained 5% fetal bovine serum. Monolayers were stained 2 d later with a 1: 20,000 dilution of neutral red. When examined 24 h later, 7 of the 240 wells contained a single clone. The medium and the remaining cell monolayers were removed from these seven wells, diluted with fresh medium, and aliquots were inoculated onto confluent monolayers of SME cells. 2 d later, the monolayers showed extensive cytopathology, and the medium and cells were harvested. Six of the seven clones were tested for their ability to produce diabetes in mice and two of these clones, one diabetogenic and the other nondiabetogenic, were plaque-purified two additional times. In brief, material from the original clones was diluted, inoculated onto confluent monolayers of SME cells, overlaid with methylcellulose medium, and stained with neutral red. Monolayers showing a single distinct circular plaque were selected, and plaques from these plates were harvested with a micropipette. This material was diluted in medium, passaged in SME cells, and tested in mice. The plaque purification procedure was repeated a third time.
Glucose and Insulin Assays. Glucose levels (plasma) were measured, and glucose-tolerance tests were performed as described previously (7) . Nonfasting glucose levels were measured 7 and 14 d after infection, and single-point 60-min glucose-tolerance tests were performed 10 and 17 d after infection. The data obtained on these 4 d were used to calculate the glucose index (7) for each mouse. The mean glucose index of 110 uninfected mice was 145:1= 19 mg/dl. Any mouse with a glucose index >240 mg/dl (5 SD above the mean) was scored as diabetic. In some experiments, only nonfasting glucose levels were determined. The mean nonfasting glucose of 69 uninfected mice was 143 :t= 21 mg/dl. In these experiments, any mouse with a nonfasting glucose >248 mg/dl (5 SD above the mean) was scored as diabetic. The concentration of immunoreactive insulin (IRI) in the pancreas and plasma of infected and uninfected mice was measured by radioimmunoassay (11, 12) .
Fluorescein Isothiocyanate (FITC)-labeled Anti-EMC Virus Antibody. Mice were immunized
intraperitoneally every week with increasing doses of EMC virus beginning with 2.0 X 10 5 PFU and ending with 2.0 X 10 6 PFU. Serum obtained after five or more injections was precipitated by ammonium sulfate, passed through a DEAE cellulose column, and the IgG fraction collected and labeled with FITC (4, 13) . Tissue sections were prepared, stained and examined as described previously (5) . Sections from uninfected animals served as controls, and the specificity of the labeled immunoglobulin was established by inhibition tests with unlabeled anti-EMC virus serum.
Interferon Assay. Interferon in the supernatant fluids of cell cultures or sera from mice was assayed as described previously (14) . In brief, monolayers of L-929 cells in microplates were incubated for 5 h at 37°121 with serial twofold dilutions of samples in a 0.1-ml vol. The cells then were challenged with 30-40 PFU of vesicular stomatitis virus (VSV). At the end of 1 h, the virus inoculum was removed, the cells were washed three times, and refed with media supplemented with 0.7% methylcellulose. Plaques were counted 48 h later. The interferon titer was expressed as the reciprocal of the highest dilution that reduced VSV plaques by 50%.
Results

Selection of Variants.
To see whether the original virus pool contained a mixture of diabetogenic and nondiabetogenic virus, individual plaques were selected, cloned, and inoculated into mice. The data in Table I show that two clones (82 and 108) produced diabetes, two (5 and 16) produced only minimal changes in glucose, and two (125 and 162) gave intermediate results. Clones 108 and 16 were plaque-purified two more times and clones 108-D2 (designated D variant) and 16-B1 (designated B variant) were studied in greater depth. These latter viruses have now been passaged at least eight times in SME cells and have retained their diabetogenic and nondiabetogenic properties.
Metabolic Alterations. Fig. 1 shows that when mice were inoculated with the D variant of EMC virus, the mean glucose level reached 500 mg/dl within 4 d after infection and remained elevated for the duration of the experiment. In contrast, mice inoculated with the B variant showed no elevation of blood glucose as compared with unitffected controls. As seen in Fig~ 2 A, the concentration of IRI in the pancreata of mice infected with the D variant was inversely related to the glucose level. At 3 d after infection; pancreatic IRI was approximately one-tenth that of uninfected animals or animals infected with the B variant. Plasma IRI of mice infected with the D variant showed an initial increase at 2 d after infection (Fig. 2 B) , presumably a result of the release'of insulin from virus-infected beta cells. This was followed by a marked Histopathologic Changes. To see whether the differences in glucose and insulin levels were related to the degree of virus-induced histopathology, sections of pancreata were prepared at different times after infection and examined microscopically. In general, islets from mice infected with the B variant showed little pathologic change (Fig. 3  A) . In contrast, islets from mice infected with the D variant showed extensive destruction of beta cells (Fig. 3 B) . Approximately 60% of the islets from mice infected with the D variant showed lymphocytic infiltration and moderate to severe destruction of the islets of Langerhans. Another 20% of the islets showed mild alterations. In contrast, <10% of the islets from mice infected with the B variant showed mild inflammatory changes.
Viral Replication. Evidence that the destruction of the islets by the D variant but
not by the B variant was a result of differences in the capacity of these viruses to infect and replicate in beta Immunologic Response. To see whether the differences in viral replication might be related to the time of appearance or titer of neutralizing antibody, mice were infected with the B or D variants, and antibody titers were determined at different times after infection. Fig. 6 shows that neutralizing antibody could be detected within 4 d after infection, but there was no difference in the time of appearance or titer of antibody when the responses to i'he B and D variants were compared. Moreover, the B and D variants are antigenically quite similar (Table II) . Antibody made against the D variant neutralized the D and B variants to about the same degree. Similarly, antibody made against the B variant neutralized the B and D variants equally well.
Inhibition by the B Variant of the Induction of Diabetes by the D Variant.
To see whether the nondiabetogenic B variant had any effect on the induction of diabetes by the D variant, the two viruses were mixed at varying ratios and inoculated into SJL/J mice. The data in Table III show that as little as 102 pFU of the D variant induced diabetes in 77% of the mice. Between 95 and 100% Of the animals developed diabetes when inoculated with >--104 PFU. In contrast, none of the animals developed diabetes when inoculated with up to 105 PFU of the B variaot. When, however, the B variant was inoculated with the D variant, at a 1:1 ratio, only 60% of the mice developed diabetes, as compared with 95% with D alone. When the B and D va÷iants were mixed at a ratio of 9:1, <--11% of the mice developed diabetes, and none developed diabetes when the B and D variants were mixed at a ratio of 99:1.
In other experiments, mice were first inoculated with the B variant (5 × 105 PFU) and, then given the D variant (5× 10 5 PFU) at~iciifferent times thereafter. The data in Table IV show that none of these animals developed diabetes. i n d u c t i o n o f d i a b e t e s b y t h e D v a r i a n t if t h e i m m u n e r e s p o n s e to t h e f o r m e r o c c u r r e d m o r e r a p i d l y or r e s u l t e d in h i g h e r a n t i b o d y titers, T h e d a t a in Fig. 6 a n d T a b l e II s h o w t h a t this is n o t t h e case. F u r t h e r e v i d e n c e t h a t t h e i m m u n e r e s p o n s e to t h e B v a r i a n t is n o t r e s p o n s i b l e for i n h i b i t i o n o f d i a b e t e s b y t h e D v a r i a n t c o m e s f r o m cell c u l t u r e e x p e r i m e n t s t h a t b y p a s s t h e i m m u n e response. S M E cells w e r e i n f e c t e d ' w i t h At the times indicated, pancreata were removed from two mice, the islets were isolated, homogenized, and assayed for infectious virus on SME cells (9) . Similarly, hearts were removed from the same mice, homogenized, and assayed for infectious virus. fluids were examined for interferon (Fig. 7 B) , the D variant induced little if any interferon (<10), whereas sttbstantial amounts of interferon were induced within 12 h by the B variant. The mixed pool, which contained both the B and D variants, induced intermediate amounts of interferon. Although there was a marked difference in the induction of interferon by the B and D variants, both of these variants were equally sensitive to the antiviral action of mouse interferon when tested on SME cells (data not shown).
Mechanism of Inhibition of the Induction of Diabetes. The B variant might inhibit the
To see whether the B and D variants induced different amounts of interferon in vivo, mice were infected, and, at various times thereafter, sera were drawn and assayed for interferon. Fig. 8 shows that substantial amounts of interferon were induced by the B variant within 10 h. In contrast, peak interferon tilers were not reached until Table  V shows that certain strains of mice developed diabetes, whereas others did not. The spectrum of host susceptibility, in general, was similar to that observed previously with the M variant (6) (7) (8) , except the glucose indexes and the percentage of animals developing diabetes were higher with the D variant. In previous experiments, the A/ J strain of mice showed abnormal glucose tolerance tests but were not diabetic, whereas in the present experiment -50% of the A/J mice developed diabetes.
Discussion
The experiments reported here show that our stock pool of EMC virus contains two variants: one diabetogenic and the other nondiabetogenic. The diabetogenic D variant infects and destroys pancreatic beta cells, thus resulting in hypoinsulemia and hyperglycemia, whereas the nondiabetogenic B variant causes little, if any, beta cell damage.
Why the D variant, but not the B variant, infects and destroys pancreatic beta cells is still not known. One possibility is that differences exist in the capsid polypeptides of the B and D variants. Viral receptors on the surface of beta cells may recognize these differences allowing the D but not the B variant to infect beta cells. Another possibility is that the host responds immunologically more rapidly to the B than to the D variant, thereby eliminating the infection before substantial beta cell damage has occurred. However, our experiments indicate that the time of appearance and magnitude of the immune response to the D and B variants are quite similar. A third possibility, presently under investigation, is that the higher interferon titers induced by the B variant in the circulation of mice actually protects beta cells from infection by the B variant. (Table IV) . Because, in our experiments, interferon disappeared from the circulation within 4 d after inoculation of the B variant (Fig. 8) , the protection observed after 4 d is most likely a result of the presence of cross-reacting neutralizing antibody. Thus, interferon and antibody, acting alone or in combination, appear to contribute to the B variant-induced inhibition of diabetes.
TABLE V
Induction of Diabetes by the D Variant in Different Inbred
It has been known for some time that only certain inbred strains of mice are susceptible to EMC virus-induced diabetes (2, (6) (7) (8) . The present study with the D variant supports this observation. Moreover, the hyperglycemia caused by the D variant was often more severe than that observed in earlier experiments with our stock EMC virus pool, which suggests that, in those experiments, the B variant may have inhibited the development of diabetes. It also has been proposed that the genetic differences in susceptibility might be related to the number or type of EMC virus receptors on the surface of cells (15, 16) . The inhibition of diabetes by interferon raises still another possibility: that genetic factors might control the host's interferon response to infection with the D variant. Ongoing experiments, however, indicate that the time of appearance and amount of interferon produced in response to the D variant is approximately the same in diabetes-resistant C57BL/6J mice and diabetes-prone SjL/j mice. Interferon, nonetheless, may be important if beta cells from C57BL/6J mice, as compared with SJL/J mice, are more sensitive to the antiviral action of interferon and are thus rendered resistant to infection and the subsequent development of diabetes. Differences in the sensitivity of certain cells to the antiviral action of interferon have been demonstrated in other systems (17, 18) .
Whether viruses play anything more than a minor role in the etiology of insulindependent diabetes mellitus remains to be established (3, 19, 20) , but the experiments with D and B variants illustrate some of the potential difficulties that might be encountered in attempting to isolate and identify diabetogenic viruses in the human population. First, by neutralization tests, it was not possible to distinguish the diabetogenic from the nondiabetogenic variant of EMC virus. Similar problems might very well be encountered when searching for diabetogenic variants of common human viruses by standard serologic techniques. Second, because our pool of EMC virus contained a mixture of diabetogenic and nondiabetogenic variants that could not be distinguished antigenically or morphologically, each virus plaque had to be tested individually for diabetes in animals. If the nondiabetogenic particles in the pool had greatly outnumbered the diabetogenic particles, the chance of isolating the diabetogenie variant would have been greatly reduced. In our EMC virus pool, the two variants appear to have been present in nearly equal amounts; and, once the diabetogenic variant was plaque purified, it remained stable on passage in SME cells. In contrast, attempts to isolate and plaque purify a diabetogenic variant from a pool of Coxsackie virus B4 that produces diabetes in mice (21) has thus far been unsuccessful (A. Toniolo and G. W. Jordan. Unpublished data.). Presumably, the nondiabetogenic virus is in great excess. Third, as demonstrated in the present report, diabetogenic variants in virus pools may not always be detected when inoculated in animals because of interference produced by nondiabetogenic variants. Moreover, passage in certain tissue-culture cell lines of virus pools that contain a mixture of variants might favor replication of the interfering or non-beta tropic variant. This may account for the poor, and sometimes changing, diabetogenicity of some of our virus pools (5) . Lastly, the studies with EMC virus have shown that only certain inbred strains of mice will develop diabetes and that susceptibility is genetically controlled (6) (7) (8) (9) (10) . Although the strains of mice that are diabetes prone or diabetes resistant are known for EMC virus, other strains of mice or species may be required to demonstrate the potential diabetogenicity of human isolates.
Summary
Plaque purification of the M variant of encephalomyocarditis (EMC) virus resulted in the isolation of two stable variants: one diabetogenic and designated D and the other nondiabetogenic and designated B. When the D variant was inoculated into SJL/J male mice, hypoinsulinemia and hyperglycemia developed in >90% of the animals. In contrast, none of the mice inoculated with the B variant developed diabetes. Histologic examination of pancreata from mice infected with the D variant revealed insulitis and necrosis of beta cells, whereas islets from mice infected with the B variant showed little, if any, change. When islets were assayed for infectious virus, 10 times more virus was recovered from animals inoculated with the D as compared with the B variant. Moreover, -60% of islet cells from mice infected with the D variant contained viral antigens when stained with fluorescein-labeled anti-EMC virus antibody, whereas <5% of islet cells from animals infected with the B variant contained viral antigens.
Co-infection experiments showed that the induction of diabetes by the D variant was inhibited by the B variant. When the B and D variants were mixed together at B:D ratios of 1, 9, and 99, diabetes developed in 60, 11, and 0% of the mice, respectively. Tissue-culture experiments revealed that the B variant induced considerably more interferon than the D variant, and studies in animals showed that interferon appeared earlier and in greater amounts in the circulation of mice infected with the B as compared with the D variant. These studies suggest that the induction of interferon by the B variant is, at least in part, responsible for the inhibition of diabetes by the D variant.
